Log in to save to my catalogue

Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials

Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1676150275

Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials

About this item

Full title

Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials

Publisher

United States: Public Library of Science

Journal title

PloS one, 2015-04, Vol.10 (4), p.e0125700-e0125700

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Blue Cone Monochromacy (BCM) is an X-linked retinopathy caused by mutations in the OPN1LW / OPN1MW gene cluster, encoding long (L)- and middle (M)-wavelength sensitive cone opsins. Recent evidence shows sufficient structural integrity of cone photoreceptors in BCM to warrant consideration of a gene therapy approach to the disease. In the present st...

Alternative Titles

Full title

Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1676150275

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1676150275

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0125700

How to access this item